Show:
- Latest 6 months
- 2019
- 2018
- 2017
- 2016
Loading...
-
Invitation to presentation of Orexo´s Full Year Report incl. Q4 2018, on January 30Jan 22 2019
-
Actavis infringes Orexo’s long term Zubsolv® US patent ´330Jan 11 2019
-
Orexo hosts Capital Markets Day today in Stockholm, SwedenDec 6 2018
-
US Court of Appeals denies Actavis’s petition for rehearing regarding validity of the Zubsolv® patentNov 30 2018
-
Agenda – Orexo Capital Markets Day, Stockholm, Sweden, Dec. 6Nov 28 2018
-
Orexo to host a Capital Markets Day on Dec. 6 with the US president´s former advisor as keynote speakerNov 8 2018
-
Save the date: Orexo to host Capital Markets Day on Dec. 6 with the US president´s former advisor as key note speakerOct 24 2018
-
Invitation: “The successful defence of Zubsolv® – Experiences from pharmaceutical patent litigation in the US”Oct 22 2018
